Member News

PLG Introduction to Healthcare Business Development Training Course

 

PLG Introduction to Healthcare Business Development Training Course

Monday 18th-Wednesday 20th November
London
https://plg-group.com/training/introductory-training-course/

Introduction to Healthcare Business Development is a three-day training course covering the key elements of Licensing and Business Development. It has a 12 strong faculty providing guidance on best practice using case study material. It also includes a hands-on example of negotiating a deal.

Addenbrooke’s Charitable Trust’s Innovation Forum

 

Addenbrooke’s Charitable Trust’s Innovation Forum aims to offer local companies with an interest in healthcare an insight into challenges faced at Cambridge University Hospitals. This is an opportunity to gain an ‘under the bonnet’ insight into a key challenge faced by the NHS on a daily basis: Frailty.

In the past 12 months, there have been more than 18,500 emergency admissions to Addenbrooke’s of those over 65.

Member event: KE Best Practice Group kick-off meeting

The Knowledge Exchange Team at Cranfield University would like to invite you to join the Knowledge Exchange Best Practice Group.  This Group has been established to provide a forum where KE practitioners in higher education have an opportunity to discuss best practice, gain insights and updates on the KE landscape and build a support network.

How do R&D teams evaluate new opportunities?

GUEST BLOG by IN-PART

Written by Daniel Judd. Edited by Alex Stockham. Originally published on the IN-PART website

 

Presenting the right information

When an R&D professional reviews an opportunity to collaborate with a university, the decision to pass or to learn more ultimately comes down to whether they have all the relevant information to hand. If a project summary doesn’t have the right information, the perfect company will often pass or lose interest. 

CRACK IT Solutions: In vitro platform for retinal toxicity assessment and disease modelling

In vitro platform for retinal toxicity assessment and disease modelling

Newcells Biotech Ltd. seek companies able to provide ocular compounds and corresponding in vivo/in vitro data, to validate their retinal pigmented epithelium (RPE) model.